When Peritoneal Metastasis Makes Treatment Decisions More Complex

Peritoneal metastasis can create uncertainty about diagnosis, treatment selection, surgical eligibility and quality of life. Understanding these challenges is an important first step toward informed decision-making.

AI-generated educational illustration: imaging. Not a patient record or photograph of the treating hospital.

Difficult-to-Detect Disease

Small peritoneal deposits may be difficult to identify on routine imaging, making further clinical assessment important.

AI-generated educational illustration: surgery. Not a patient record or photograph of the treating hospital.

Limited Surgical Eligibility

Not every patient is suitable for major surgery. Disease distribution and overall health play essential roles in treatment planning.

AI-generated educational illustration: infusion. Not a patient record or photograph of the treating hospital.

Decisions After Chemotherapy

When treatment response is uncertain, patients may need a review of current findings and available next steps.

AI-generated educational illustration: assessment. Not a patient record or photograph of the treating hospital.

Risk of Bowel Obstruction

Peritoneal disease can affect bowel function and may lead to symptoms that require urgent medical evaluation.

AI-generated educational illustration: recovery. Not a patient record or photograph of the treating hospital.

Treatment-Related Risks

Complex surgery and systemic treatments may involve significant risks, recovery needs and difficult trade-offs.

AI-generated educational illustration: records. Not a patient record or photograph of the treating hospital.

Seeking Another Medical Perspective

A specialist second opinion can help patients better understand recommendations and prepare informed questions for their treating team.

AI-adapted portrait based on Professor Hui Wang's original photograph; illustrative office background.
AI-adapted portrait based on Professor Hui Wang's original photograph; illustrative office background.
EXPERT PROFILE

Meet Professor Hui Wang

Professor Hui Wang is a Chief Physician and Doctoral Supervisor at The Sixth Affiliated Hospital of Sun Yat-sen University in Guangzhou, China. He serves as Director of the Third Division of Colorectal Surgery.

His work focuses on colorectal surgery, particularly the diagnosis, clinical management and research of colorectal peritoneal metastasis.

His team has contributed to research on cytoreductive surgery, HIPEC-related treatment strategies, peritoneal cell-free DNA, artificial intelligence-assisted detection and innovative biomaterials.

 View the hospital’s official expert profile.

Clinical and Academic Focus

The HIPEC training scene is based on Professor Hui Wang’s portrait and is not a photograph of an actual training session.

AI educational illustration of colorectal anatomy, imaging and pathology for complex surgical planning.

Colorectal Surgery Expertise

A clinical and research background in colorectal disease and complex surgical management.

Explore Colorectal Surgery
AI educational illustration of peritoneal lining and metastatic deposits for specialized disease assessment.

Peritoneal Tumor Specialization

Professional work focused on improving understanding and management of peritoneal metastasis.

Explore Specialization
AI educational reconstruction based on Professor Hui Wang's portrait demonstrating HIPEC simulation training and a procedural checklist; not actual clinical care.

Standardized Clinical Education

Participation in training activities related to standardized HIPEC practice and peritoneal tumor care.

Explore Clinical Education
AI educational illustration connecting oncology, pathology, molecular diagnostics, medical imaging and biomaterials research.

Multidisciplinary Research Collaboration

Research involving oncology, pathology, molecular diagnostics, imaging and medical biomaterials.

Explore Research Collaboration

Explore Key Clinical Evaluation Pathways

Treatment decisions for peritoneal metastasis require careful consideration of the underlying cancer, extent of disease, previous treatment and overall health.

AI-generated educational illustration: disease. Not a patient record or photograph of the treating hospital.

Peritoneal Disease Assessment

Understanding the distribution and extent of peritoneal disease helps inform further evaluation and treatment discussions.

AI-generated educational illustration: crs. Not a patient record or photograph of the treating hospital.

Cytoreductive Surgery (CRS)

CRS aims to remove visible tumor deposits in appropriately selected patients when meaningful cytoreduction is considered feasible.

Explore Cytoreductive Surgery
AI-generated educational illustration: hipec. Not a real patient, hospital or clinical result.

HIPEC Evaluation

Explore the role, limitations and evidence surrounding heated intraperitoneal chemotherapy in specific clinical circumstances.

AI-generated educational illustration: systemic. Not a real patient, hospital or clinical result.

Systemic Treatment Review

Review the relationship between previous anticancer treatment, current disease status and potential future options.

AI-generated educational illustration: pathology. Not a real patient, hospital or clinical result.

Molecular and Prognostic Assessment

Understand how tumor biology, molecular findings and other clinical factors may contribute to individualized discussions.

AI-generated educational illustration: support. Not a real patient, hospital or clinical result.

Symptom and Supportive Care

Address complications, nutrition, bowel function and quality-of-life needs as part of comprehensive care.

AI-generated educational illustration: anatomy. Not a real patient, hospital or clinical result.
INDIVIDUALIZED DECISIONS

What Determines Whether a Treatment Approach May Be Suitable?

The suitability of cytoreductive surgery, systemic treatment or other interventions depends on multiple factors. No single test can determine the appropriate pathway for every patient.

Six Factors to Discuss With Your Medical Team

AI-generated educational illustration: primary cancer. Conceptual medical illustration, not a patient scan.

Primary Cancer Type

The origin, pathology and biology of the cancer influence treatment recommendations.

AI-generated educational illustration: peritoneal extent. Conceptual medical illustration, not a patient scan.

Extent of Peritoneal Disease

The distribution and burden of peritoneal metastases are important considerations.

AI-generated educational illustration of outside-peritoneum. Not a patient scan.

Disease Outside the Peritoneum

Additional metastatic sites may influence the overall treatment strategy.

AI-generated educational illustration: previous treatments. Clinician likeness based on Professor Hui Wang's portrait; fictional consultation scene, not an actual patient encounter.

Previous Treatments

Past surgery, chemotherapy and other therapies help guide discussions about future options.

AI-generated educational illustration of health-fitness. Clinician likeness based on Professor Hui Wang; fictional scene, not an actual patient encounter.

General Health and Fitness

Performance status, organ function, nutrition and other medical conditions influence treatment risks.

AI-generated educational illustration of benefits-risks. Clinician likeness based on Professor Hui Wang; fictional scene, not an actual patient encounter.

Expected Benefits and Risks

Potential outcomes, complications, quality of life and patient preferences should be considered together.

CRS and HIPEC: Understanding the Differences

CRS and HIPEC are not suitable for every patient. Their use should be discussed with an experienced multidisciplinary team.

AI-generated educational illustration: crs-overview. Not a real patient, hospital or clinical result.

What Is Cytoreductive Surgery?

Cytoreductive surgery (CRS) is a complex surgical approach intended to remove visible tumor deposits from the abdominal cavity when appropriate. The possibility of complete or near-complete removal, disease distribution, surgical risks and the patient’s overall condition are central considerations.

Explore Cytoreductive Surgery
AI-generated educational illustration: hipec-equipment. Not a real patient, hospital or clinical result.

What Is HIPEC?

Hyperthermic intraperitoneal chemotherapy (HIPEC) involves circulating heated chemotherapy solution within the abdominal cavity during a specialized procedure. Its potential role depends on the underlying disease, treatment protocol and available clinical evidence.

Explore HIPEC

Questions Before Considering CRS or HIPEC

AI educational reconstruction of Professor Hui Wang reviewing imaging, pathology and general health before major abdominal surgery.

Patient Selection

Why specialized evaluation is essential before considering major abdominal surgery.

Educational abdominal model and imaging showing peritoneal disease distribution and relationships with abdominal organs for surgical planning.

Surgical Complexity

Understanding the extent of surgery and potential impact on abdominal organs.

AI educational reconstruction of Professor Hui Wang discussing postoperative monitoring, nutrition, mobility and ongoing support with a patient and caregiver.

Complications and Recovery

Considering postoperative complications, hospital recovery and longer-term support.

Conceptual evidence review comparing HIPEC, systemic treatment and supportive approaches; individual assessment is required.

Evidence and Alternatives

Reviewing HIPEC evidence, systemic treatment options and other approaches based on individual circumstances.

Advancing Research in Peritoneal Metastasis

Professor Hui Wang and his research collaborators have contributed to studies exploring earlier detection, individualized prognosis, treatment strategies and biomaterials relevant to colorectal cancer and peritoneal disease.

Investigational technologies are not necessarily approved, clinically validated or available as routine patient services.

AI-generated educational illustration: cfdna. Not a real patient, hospital or clinical result.

Peritoneal Cell-Free DNA Research

Research has investigated peritoneal cell-free DNA as a potential biomarker for detecting colorectal peritoneal metastasis.

AI-generated educational illustration: ai. Not a real patient, hospital or clinical result.

AI-Assisted Disease Detection

Published work has explored image-based deep learning methods for identifying synchronous peritoneal disease in colorectal cancer.

AI-generated educational illustration: molecular. Not a real patient, hospital or clinical result.

Prognostic and Molecular Research

Research into molecular and clinical characteristics may help improve understanding of prognosis and disease behavior.

AI-generated educational illustration: hydrogel. Not a real patient, hospital or clinical result.

Innovative Biomaterials

Experimental biomaterials research has explored new approaches relevant to localized antitumor strategies and surgical applications.

When Might a Specialist Second Opinion Be Helpful?

Patients and families may consider an additional medical opinion when important questions remain about diagnosis, treatment selection or supportive care.

Severe abdominal pain, persistent vomiting, inability to pass stool or gas, or other potentially urgent symptoms require prompt local medical attention.

AI-generated educational illustration: waiting. Not a real patient, hospital or clinical result.

Newly Diagnosed Peritoneal Metastasis

You have recently received a diagnosis and want to better understand the available treatment approaches.

AI-generated educational illustration: opinion. Fictional scene, not a real patient or hospital.

Uncertain Surgical Eligibility

You have been told surgery may not be appropriate and would like clarification of the clinical reasoning.

AI-generated educational illustration: followup. Fictional scene, not a real patient or hospital.

Disease After Previous Treatment

Your disease has progressed or recurred following treatment, and you have questions about the next steps.

AI-generated educational illustration: imaging-review. Fictional scene, not a real patient or hospital.

Unclear Imaging Findings

Your clinical findings suggest possible peritoneal disease, but imaging or other test results remain uncertain.

AI-generated educational nutrition consultation illustration. Fictional scene.

Complex Symptoms or Complications

You are experiencing bowel-related symptoms, nutritional difficulties or other challenges that require coordinated clinical management.

AI-generated educational illustration: case-preparation. Fictional scene, not a real patient or hospital.

Seeking Another Specialist Perspective

You wish to understand the potential benefits and risks of different treatment strategies before making an informed decision.

AI-generated conceptual illustration of colorectal research, pathology and education with Guangzhou skyline; not a photograph of The Sixth Affiliated Hospital or its facilities.
AI-generated conceptual illustration of colorectal research, pathology and education with Guangzhou skyline; not a photograph of The Sixth Affiliated Hospital or its facilities.

Clinical and Academic Background in Guangzhou, China

The Sixth Affiliated Hospital of Sun Yat-sen University

Professor Hui Wang serves as Director of the Third Division of Colorectal Surgery at The Sixth Affiliated Hospital of Sun Yat-sen University. His clinical and academic work includes specialized activities related to peritoneal tumors, colorectal cancer research and professional education.

Official hospital expert information

Selected Research Publications

Eight selected publications spanning detection, treatment evaluation, prognosis, tumor biology and biomaterials. Swipe to explore on mobile.

Images are AI-generated research illustrations, not original study figures. Experimental findings do not establish routine clinical availability or individual treatment outcomes.

AI-generated conceptual research illustration: Peritoneal cfDNA Detection. Not an original study figure, patient scan or clinical result.

Clinical Epigenetics · 2023

Peritoneal cfDNA Detection

Read publication
AI-generated conceptual research illustration: AI-Assisted Imaging. Not an original study figure, patient scan or clinical result.

Annals of Surgery · 2022

AI-Assisted Imaging

Read publication
AI-generated conceptual research illustration: CRS With or Without HIPEC. Not an original study figure, patient scan or clinical result.

Frontiers in Oncology · 2022

CRS With or Without HIPEC

Read publication
AI-generated conceptual research illustration: BRAF and Prognosis. Not an original study figure, patient scan or clinical result.

Gastroenterology Report · 2023

BRAF and Prognosis

Read publication
AI-generated conceptual research illustration: Risk Factors for Metastasis. Not an original study figure, patient scan or clinical result.

Frontiers in Oncology · 2022

Risk Factors for Metastasis

Read publication
AI-generated conceptual research illustration: Injectable Hydrogel Research. Not an original study figure, patient scan or clinical result.

Advanced Materials · 2025

Injectable Hydrogel Research

Read publication
AI-generated conceptual research illustration: Lipids and Tumor Spread. Not an original study figure, patient scan or clinical result.

International Journal of Biological Sciences · 2022

Lipids and Tumor Spread

Read publication
AI-generated conceptual research illustration: Biomaterials for Peritoneal Disease. Not an original study figure, patient scan or clinical result.

Smart Medicine · 2023

Biomaterials for Peritoneal Disease

Read publication
AI-generated educational illustration: pathway. Fictional scene, not a real patient or hospital.
INTERNATIONAL PATIENT PATHWAY

How International Patients Can Begin an Assessment Inquiry

A structured inquiry can help clarify what information is needed before any specialist consultation or travel decision.

Consultation availability, the receiving provider, required records and fees must be confirmed before making travel plans.

Four Steps Toward an Informed Discussion

Prepare your case, confirm consultation details, discuss the assessment and explore any recommended next steps.

AI-generated illustration of an organized case summary, medical reports, imaging and questions prepared for specialist review.

1. Share Your Case & Records

Share a brief summary of your diagnosis, previous treatment and questions. Prepare pathology reports, diagnostic imaging, operative notes and recent treatment summaries for review through a confirmed secure process.

AI-generated illustration of a calendar, medical records checklist and fee estimate for confirming consultation arrangements.

2. Confirm Consultation Details

Where available, confirm specialist consultation arrangements, required records and applicable fees before proceeding.

AI-generated conceptual consultation setting with medical imaging and reports for discussing an individualized assessment; not a real facility.

3. Discuss the Medical Assessment

A qualified medical professional may review your information and explain clinical considerations and possible next steps.

AI-generated illustration of hospital and travel planning after in-person care is recommended and accepted.

4. Explore Further Coordination

If in-person care in China is recommended and accepted, explore hospital arrangements and practical coordination.

INTERNATIONAL PATIENT INQUIRY

Tell Us About Your Medical Case

Contact medChina to explore a specialist assessment pathway for peritoneal metastasis.

Briefly share your diagnosis, confirmed or suspected peritoneal metastasis, previous treatment and questions.

Read our Privacy Policy

  • You may upload relevant medical records as PDF or images, each under 20 MB. Share only records you are authorized to provide.
  • Consultation availability, arrangements and fees are confirmed separately.
  • Treatment requires individual assessment. Published research does not establish routine availability.

Please review our privacy policy before submitting. An inquiry does not establish a doctor-patient relationship or guarantee consultation, treatment or admission.

Frequently Asked Questions About Peritoneal Metastasis

Clear answers to common questions before a specialist discussion.

What is peritoneal metastasis?

Can colorectal peritoneal metastasis be treated?

What is cytoreductive surgery (CRS)?

What is HIPEC?

Is HIPEC suitable for every patient?

Can peritoneal metastasis be missed on CT imaging?

What medical records are helpful for a second opinion?

Can international patients seek a specialist opinion in China?